Highlights From the Inaugural COPD7USA Conference: Focus on Treatment Challenges in COPD.

Slides:



Advertisements
Similar presentations
Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomized control trial (BMJ. 2010;341:c5462)
Advertisements

GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
By Scott Cerreta, BS, RRT Director of Education Expectations after Pulmonary Rehabilitation.
ABCDABCD mMRC < 2 CAT 2 CAT > >2>2 RISK GOLD RISK Exacerbation TypeCharatteristicSpirometric classification Exacerbation Per.
Postmarketing Clinical Studies of A 1 PI Products L. Ross Pierce, M.D. Medical Officer, Clinical Review Branch, Div. of Hematology, FDA.
EARLY TREATMENT: USE THE BEST FIRST Early treatment with pharmacological approach Focus on COPD Stage II Pierluigi Paggiaro Cardio-Thoracic and Vascular.
Planning, COPD Hot Topics and CSA preparation Ruth Gooch 11/1/12.
PREVENTING COPD EXACERBATIONS
GOLD Clasification Antonio Anzueto MD Professor Medicine University of Texas.
CHRONIC OBSTRUCTIVE PULMONARY DISEASE Treatment Opportunities in a Heartsink Disease Jim Reid.
Clinical Knowledge Summaries CKS Chronic obstructive pulmonary disease (COPD) - management Management of stable COPD in primary care, focusing on drug.
Hemiplegia Dr. Shamekh M. El-Shamy. Treatment of Hemiplegia Principles : Principles :
Dr. Danny Galdermans Dept Respiratory Medicine ZNA Middelheim Antwerp
COPD Alison Boland StR Respiratory medicine. Aims & Objectives Overview of COPD Recap basic knowledge Update on COPD Know when to use nebulisers and home.
COPD GUIDELINES Sarah Cowdell. WHY GUIDELINES MATTER Predicted to be the third leading cause of death by 2030 Cause of over 30,000 deaths in the UK yearly.
COPD Management of Stable COPD Shyam Rao May 2014.
Practice Support Program in COPD: South Okanagan Project COPD CARE Algorithm South Okanagan, Interior Health Patricia Rattee RRT, CRE Shannon Walker MD,
Chronic Obstructive Pulmonary Disease
Update on COPD Management
Definition COPD def- A disease state characterized by air flow limitation that is not fully reversible It is expected to be the 3 rd leading cause of.
Real life COPD patients compared to large COPD study populations An UNLOCK external validity study A.L. Kruis, LUMC, Leiden, the Netherlands B. Stallberg,
LSU Journal Club Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD WISDOM study H. Magnussen MD, et al. Nisha Loganantharaj, PGY1 April 21,
내과 R2 이지훈 N Engl J Med Sep 8.
Prescribing for patients with COPD Evidence Update Emma Blanden- Pharmacist.
Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind,
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Use of Inhaled Corticosteroids and the Risk.
Management of stable chronic obstructive pulmonary disease (2) Seminar Training Primary Care Asthma + COPD D.Anan Esmail.
Dr Julius Cairn. Introduction - update COPD Exacerbations Pulmonary rehabilitation Lung cancer - NSCLC Treatments for patients with limited lung function.
Antibiotics in Addition to Systemic Corticosteroids for Acute Exacerbations of Chronic Obstructive Pulmonary Disease Johannes M.A. Daniels; Dominic snijders;
Health, Happiness & Community Sing Your Lungs Out Study Group; Medical Research Institute of New Zealand Dr Amanda McNaughton, Dr Sarah Aldington, Gayle.
Chronic Obstructive Pulmonary Disease Clinacal Pharmacy.
N Engl J Med 2012 ; 367 : Huib A.M. Kerstjens, M.D., Michael Engel, M.D., Ronald Dahl, M.D., Pierluigi Paggiaro, M.D., Ekkehard Beck, M.D.,
Current management of COPD and when to refer?
Medical Grid Bonita Hung 2005/5/13.
5. Example - the Coronary Drug Project (CDP)
COPD Tutoring – Part 1 By Alaina Darby.
Differences in Response to Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease Respiration 2011;81:196–205.
Blood eosinophils as a biomarker in alpha 1 antitrypsin deficiency
Practical Recommendations for COPD:
COPD.
Lung Cancer Audit to patient Reference Group
Treatment Strategies in Mild to Moderate COPD
Prof Dr Guy JOOS Dept Respiratory Medicine Ghent University Hospital
Alpha-1 Antitrypsin Deficiency in COPD
Dual Bronchodilation in COPD: From Clinical Trial Evidence to Clinical Practice.
What Is the Role of Dual LAMA/LABA Bronchodilation in COPD Therapy in Light of New Clinical Data?
Volume 153, Issue 4, Pages (April 2018)
Volume 153, Issue 4, Pages (April 2018)
Community Health Pearl:
A Case Challenge: Anticoagulant Choices for Acute PE
When Would You Use Single Inhaler Triple Therapy in COPD?
Case 1: Introduction. Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
A pragmatic stepped intervention cluster randomized trial
Distribution of lower extremity artery disease (LEAD) Fontaine stages over the combined chronic obstructive pulmonary disease (COPD) Global Initiative.
Long-Acting Agents in Severe COPD
Conceptual framework of the interaction between environmental exposure including smoking, alpha-1 antitrypsin (AAT) level and/or AAT genotype, other genetic.
Roflumilast negli studi di Fase III: i dati di efficacia
Management of Chronic Stable COPD
Gestione clinica della BPCO
Schematic overview of the suggested pharmacological management of chronic obstructive pulmonary disease (COPD). Schematic overview of the suggested pharmacological.
Chronic Obstructive Pulmonary Disease
Volume 150, Issue 4, Pages (October 2016)
Physician perspectives on the most useful methods for monitoring α1-antitrypsin deficiency in the clinical trial setting versus clinical practice. Physician.
Volume 128, Issue 4, Pages (April 2005)
Practical Recommendations for COPD:
Forest plot from meta-analysis carried out on four studies including high-dose N-acetylcysteine (NAC) treatment a) assessing the relative risk of chronic.
Targeted Care for COPD.
Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification based on symptom and risk evaluation. a) GOLD model of symptom/risk evaluation.
Chronic obstructive pulmonary disease (COPD) prevalence (postbronchodilator FEV1/FVC (forced expiratory volume in 1 s/forced vital capacity)
Choosing inhaler therapy for patients with stable COPD based on the Global Initiative for Chronic Obstructive Lung Disease grouping. Choosing inhaler therapy.
Presentation transcript:

Highlights From the Inaugural COPD7USA Conference: Focus on Treatment Challenges in COPD

Decline in Lung Function With Age and Smoking

ECLIPSE Findings by GOLD Stage

TORCH Placebo Groups (n = 1524)

Reduction in Mortality

TORCH and Early Treatment

UPLIFT Trial: Exacerbations

COPD Assessment in 2012

COPD Assessment in 2012

Effect of Pulmonary Rehabilitation and Pharmacotherapy in COPD

ICS + LABA Decreases Acute Exacerbations of COPD

COPD Assessment in 2012

Treatment of COPD Associated With α-1 Antitrypsin Deficiency

Thank you for participating in this activity.

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.